TP53 and non-small cell lung carcinoma: Based on findings in multiple other solid tumors that Onc-p53 elevates proteasome subunit gene expression and activity (11), we hypothesized that NSCLC cells expressing Onc-p53 might also demonstrate similar upregulation of proteasome activity and as a result, also exhibit enhanced cytotoxic sensitivity toward PIs.